to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Sales forecasts made by salespeople are usually overoptimistic and often inaccurate. This article offers the basic processes and thinking behind successful forecasting systems that rely on history instead of hope.
Owners of growing companies need to begin positioning them for sale early in the life of the firm and continue to take steps toward sale throughout the business's life, writes an entrepreneur and venture capitalist. Included are eight suggestions for doing just that.
Use this checklist to evaluate all of your funding options and to consider alternative sources of funding.
Issuing shares privately is a viable way for small and growing businesses to raise capital, exempt from many registration and reporting requirements. Here are the rules you need to know.
Steven Funk sees microcredit as an opportunity to help people worldwide become entrepreneurs.
This worksheet calculates ROI via online technology called RouteTrack, which coordinates product delivery and distribution.
Looking at ways to do a public offering, the founders of a biotech company chose a reverse merger, an alternative public offering that ultimately provided the company with access to more funding sources and higher valuation.
Raising capital at any stage of a company's growth is challenging and requires creativity and tenacity. However, these hurdles are especially difficult to conquer at the earliest stages of an enterprise's development, the author says. This article discusses where and how to raise capital at the seed level and growth stages.
Many entrepreneurs increasingly are exploring alternative ways to raise capital. This overview evaluates four of the most common alternative public equity tracks: foreign markets, corporate shells, private investment in a public equity, and direct public offerings.
Terry Bruggeman shares the tale of leading his life sciences company through the decision to obtain capital. After exploring the funding options, including VC and IPO, Bruggeman and his team decide to undertake a reverse merger.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.